3 stocks to consider buying before interest rates get slashed

With interest rate cuts very much on the cards for 2024, I’m tempted to buy these three stocks if they benefit from any reduction.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Fireworks spelling out the numbers '2024'

Image source: Getty Images

A tiny detail escaped many when the Bank of England’s monetary policy committee met last month. This small move is worth paying attention to for anyone looking for stocks to buy.

The nine members of the committee voted on interest rates and not one voted for a rate rise. So every person voted to hold or lower rates. 

That’s the first time this has happened since September 2021, sending a very clear signal to the markets: rates are coming down. 

Here are three FTSE 100 stocks I think could be good buys before the first rates cut, which could arrive as early as June. 

Big banking

Big banks will have their fingers crossed that rates don’t drop too fast – because more expensive borrowing widens margins and fattens earnings. 

Lloyds (LSE: LLOY) has been printing money of late and has the cash on hand to boost its dividend to over 5%, rising to 6% in 2024 and nearly 7% in 2025.

But banks also suffer more defaults when rates are high. Costly loans and mortgages are harder to pay and the average person isn’t exactly flush with cash, given the cost-of-living crisis. 

Lloyds, which loans out more mortgages than any other lender and booked a £1.5bn impairment charge last year, might welcome a fall in rates for these reasons. 

The bank looks to me like a good stock to buy although I’m happy with size of my position at present.

Cheap homes

With financing costing 5% or more, fewer people are taking out mortgages and that’s resulted in housebuilders like Persimmon (LSE: PSN) building fewer homes. 

The Persimmon shares have also suffered, still down 61% from their pre-pandemic high. 

A buying opportunity? I think it could be. I’m tempted to buy more.

The housing market should recover as rates come down and Persimmon is poised to take advantage. 

The housebuilder makes the cheapest homes around. Its houses sold for an average £256k in 2023, around 20% cheaper than other builders. 

These cheap homes haven’t deterred homebuyers and Persimmon properties have sold well in the last decade. 

Consumer goods

The upcoming fall in interest rates will, we all hope, be twinned with a stronger UK and global economy. 

With a fair wind, consumer spending should rise and boost cash flows of consumer goods firms like Unilever (LSE: ULVR). 

Unilever looks like a cheap buy at present, trading at 17 times earnings. 

Compare that with American rivals Procter & Gamble, at 26 times earnings, or Johnson & Johnson, at 29 times earnings. 

Its well-loved brands like Persil, Hellmann’s, Cornetto, or Dove are well-entrenched as number one names too.

What are the risks? Well, new CEO Hein Schumacher is shifting gears after a wobbly few years for the share price.

He’s mulling a spin-off of the ice cream part of the business, for one. 

But the shares lagging 25% behind recent highs looks attractive. I’d buy the shares given spare cash.

John Fieldsend has positions in Lloyds Banking Group Plc and Persimmon Plc. The Motley Fool UK has recommended Lloyds Banking Group Plc and Unilever Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »